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Epidemiological Surveys of Methicillin-Resistant Staphylococcus aureus
in Tottori Prefecture, Japan
Yoshinori Tanaka, Akiko Adachi and Miyoko Tanaka
Department of Bacteriology, Faculty of Medicine, Tottori University, Yonago 683-0826, Japan
To study the isolation frequency of methicillin-resistant Staphylococcus aureus (MRSA)
and susceptibility of MRSA to antibiotics, a questionnaire survey was performed every
half year from 1993 until 1997.  The questionnaire was sent to medical doctors, and it
asked retroactively about the isolation of S. aureus from clinical specimens.  The isolation
rate of MRSA from patients over 65 years of age was higher, and that from patients
under 16 years of age was lower, than the rates in other age groups (P < 0.01).  Ratios of
isolation of MRSA among S. aureus strains were from 12 to 38% in the clinics, from 39
to 71% in the small-scale hospitals and from 47 to 62% in large-sized hospitals.  These
isolation rates increased gradually from 1993 to 1997 (P < 0.001).  The isolation rate of
MRSA from the sputum was higher, and those from pus, pharyngeal secretion and
urine were lower, than those from feces and other specimens and from total specimens.
The isolation rate of antibiotic-resistant strains of MRSA was highest for penicillins
and cepharosporins.  MRSA was highly susceptible to arbekacin (isolation rate of
resistant strains:  3.0%) and vancomycin (3.0%), and was slightly susceptible to mino-
cycline (21%), doxycycline (24%), amikacin (39%) and dibekacin (37%).  These results
indicate that more careful surveillance of MRSA and more stringent precautions against
nosocomial infection with antibiotic-resistant MRSA are needed in hospitals even in
relatively isolated parts of Japan.
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There are many bacteria which evoke noso-
comial infections, including Escherichia coli,
Pseudomonas aeruginosa, Klebsiella, Staphy-
lococcus aureus, etc.  Antibiotic susceptibility
of these bacteria varies with genus, species and
strain.  The serious problem of nosocomial infec-
tions with multiply antibiotic-resistant bacteria
has increased since the early 1980’s (Locksley
et al., 1982; Thomson et al., 1982).  An out-
break of nosocomial infection with multidrug-
resistant S. aureus was first reported by Locksley
et al. (1982).  During a 15-month period, multiply
antibiotic-resistant S. aureus was transferred
from a burn patient to 34 patients in the hos-
pital.  Seventeen of the 34 patients died.  Typing
and plasmid analysis showed the spread of mul-
tiply resistant S. aureus from the burn unit to the
surgical intensive care unit.
In the late 1980’s, several patients died from
nosocomial infection with methicillin-resistant
S. aureus (MRSA) in Japan, resulting in some
legal proceedings against unwarranted noso-
comial infections.  We investigated contami-
nation by MRSA in Tottori Prefecture, a rela-
tively isolated prefecture of Japan.  The ques-
tionnaires were sent to members of medical
institutions in Tottori Prefecture, and the trends
of infections with MRSA in the clinics and hos-
pitals were analyzed.
Subjects and Methods
Questionnaire surveys
At first, questionnaires were sent to clinical
doctors asking whether or not specimens were
sent to a clinical laboratory for bacterial exami-
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nation.  If we got the answer “yes”, then we sent
the following questionnaires every half year
from 1993 to 1997.  The contents of the ques-
tionnaires asked the age and sex of the patient,
origins of the specimens, species of Staphylo-
coccus, antibiotic susceptibility testing and exis-
tence of any abnormal physical background.
Identification of Staphylococcus spp. and
drug susceptibility testing were usually per-
formed by standard methods.  Staphylococcus
spp. was identified using commercially avail-
able identification kits after selection by mannite-
positiveness and coagulase activity.  Antibiotic
susceptibility testing was performed by disk
methods (Barry and Thornberry, 1991) and
methicillin-resistant or oxacillin-resistant
strains of S. aureus were defined as methicillin-
resistant S. aureus (MRSA).  However, these
methods of testing might have varied in differ-
ent clinical laboratories.
Statistical analysis
Statistical analysis was performed as follows.
Significant differences between the two groups
were determined by Student’s or Welch’s t-test.
Comparisons of several groups controlled by
two factors were made by the two factor analy-
sis of variance or Friedman’s test.
Results
Total cases and hospitals
The number of clinics and hospitals was about
460 in May, 1993.  A preliminary investigation
was performed by sending the doctors in these
institutions a questionnaire about whether
microbial examinations were done or not.  The
answer was returned from 370 institutions
(80.4%).
Out of 300 medical doctors who answered
that microbial examinations were done if neces-
sary, or that the patients were sent to a big hos-
pital, an average of 57 answered the subsequent
questionnaires which we sent them twice a year.
Accordingly, the average rate of replies was
about 20%.  Most of the medical doctors in the
clinics did not have patients with bacterial
infection who needed microbial examination,
because the patients were getting better by hap-
hazard treatment with some antibiotics.
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Fig. 1.  The frequency of S. aureus isolation in various age groups and from different types of specimens.
Distribution of S. aureus strains isolated in the age groups (A) and from various specimens (B).  Total number
of strains isolated was 2,527 during a 5-year period.  The isolation frequency (percentage) from each type of
specimen is shown in parentheses.
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Fig. 2.  Isolation rates of MRSA in different kinds of
institutions.  The isolation rates of MRSA in clinics
( ), small- ( ) and large- ( ) sized hospitals and
total isolation rate ( ) were investigated every half
year.  The “1” in the Figure shows the first half of the
year and the “2” shows the latter half of the year.
The isolation rate of MRSA in clinics was signifi-
cantly lower (**P < 0.001) than that in the other
three groups, which were not significantly different
from each other.  During the period from 1993 until
1997, all four MRSA isolation rates significantly in-
creased (P < 0.001).
R
at
e 
of
 is
ol
at
io
n 
of
 M
RS
A
(%)
80
60
40
20
0
1 2 1 2 1 2 1 2 1 2
'93 '94 '95 '96 '97
**
Isolation of S. aureus in the age groups
and from various types of specimens
The specimens of 1,391 men and 1,136 women
were examined from 1993 until 1997 (Fig. 1A).
The ratio of men to women was approximately
5 to 4; the difference between the number of
men and women was not significantly different.
Comparison of the number of specimens in the
various age groups showed that greater num-
bers of specimens were isolated from the group
under 16 years of age (16%) and the group over
65 years of age (66%) than from other age
groups.  Isolation rates of S. aureus in the age
groups from 16 to 30 years of age, from 31 to 50
years of age and from 51 to 65 years of age were
4.2%, 5.5% and 8.7%, respectively.  These age
groups showed similar ratios of men to women.
A larger proportion of specimens from women
were isolated from the group over 65 years of
age (70%) as compared with the proportion
from the men isolated from the group over 65
years of age (62%).
In testing the kinds of specimens from which
S. aureus was isolated (Fig. 1B), sputum (34%)
and pus (25%) were the most frequent, and pha-
ryngeal secretion (16%) and urine (11%) were
the next most frequent.  There was a low rate of
isolation from sputum, and relatively higher
rates from pus and urine in 1993 (data not
shown).  The rate of isolation from sputum
increased after 1994 and that from pus varied
from year to year.  Rates of isolation from nasal
mucus (rhinorrhea) and urine did not vary from
year to year.  There were few isolations from
blood specimens, and they were included in the
group of “Others”.
Isolation rate of MRSA
The rates of isolation of S. aureus strains from
clinical specimens in the period from 1993 until
1997, are shown in Fig. 2.  In the clinics, 25 to
75 cases of S. aureus were identified during
every half-year term and the isolation rate of
MRSA varied from 12 to 38%.  These isolation
rates were significantly lower than those in
small- and large-sized hospitals (P < 0.001).
The isolation rate of MRSA in relatively small-
sized hospitals and large-sized hospitals grad-
ually increased from 39% and 47% in the first
half of 1993 to over 71% and 62% in the second
half of 1997, respectively.  Isolation rates of
MRSA in clinics and in small- and large-sized
hospitals increased significantly as the time
elapsed during the period from 1993 until 1997
(P < 0.001).
The total numbers of S. aureus and MRSA
isolated between 1993 and 1997 were about
3,000 and 2,000, respectively.  The isolation
rate of MRSA increased gradually and signif-
icantly from 47% in the first half of 1993 to
63% in the second half of 1997 (P < 0.001).
Isolation of MSSA and MRSA from speci-
mens in various age groups and isolation
from various types of specimens
Out of all S. aureus-positive specimens, 66%
were from patients more than 65 years of age,
and 16% were from patients under 16 years of
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Fig. 4.  Isolation of MSSA and MRSA from
patients with compromised conditions.
MSSA ( ) and MRSA ( ) were isolated
from patients with background diseases, im-
munosuppresive treatments or local injuries,
or from aged and/or bedridden persons.  The
isolation ratio of MRSA to MSSA from the
patients with immunosuppresive treatments
is significantly higher than the ratios from the
patients of other groups (**P < 0.001).
Fig. 3.  Isolation of MSSA and MRSA in various age groups and their isolation from various types of speci-
mens.  MSSA ( ) and MRSA ( ) were isolated from various specimens.  (A) isolation of MSSA and MRSA
in age groups.  (B) isolation of MSSA and MRSA from various specimens.  The asterisks indicate a signifi-
cant difference between the ratios of MSSA to MRSA in the groups with asterisks and the groups without
asterisks (**P < 0.001).
age (Fig. 1A).  The variance of the number of
specimens from which methicillin-sensitive S.
aureus (MSSA) was isolated was not the same
as that of MRSA (Fig. 3A).  The isolation rate
of MRSA in the age group under 16 years of age
was significantly lower (P < 0.001) and that in
the age group over 65 years of age was signifi-
cantly higher than those in the groups from 16 to
30 years of age, from 31 to 50 years of age and
from 51 to 65 years of age, and higher than the
isolation rate of MRSA in the total specimens.
The isolation rates of MRSA from the patients
in the age groups from 16 to 30 years of age,
from 31 to 50 years of age and from 51 to 65
years of age and the isolation rate of MRSA
from the total specimens, were 54%, 44%, 52%
and 61%, respectively, and were not significant-
ly different.
The numbers of MSSA and MRSA strains
isolated from specimens between 1993 and 1997
are shown in Fig. 3B.  There were large vari-
ances in the numbers of MSSA and MRSA.  The
isolation rate of MRSA from sputum was higher,
and those from pus, pharyngeal secretion and
urine were lower than that of MSSA from each
specimen (P < 0.001).  The isolation rates of
MRSA from rhinorrhea, feces, others and total
specimens were similar to those of MSSA.  Many
specimens of sputum were tested from patients
over 65 years of age (87% of total specimens of
sputum), whereas pharyngeal secretion speci-
mens were largely from patients under 15 years
of age (51% of total specimens of pharyngeal
secretion).
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Background of S. aureus infection
We investigated whether or not patients with S.
aureus infection were compromised hosts.  As
shown in Fig. 4, the isolation rate of MRSA
from patients with immunosuppressive treat-
ments was clearly higher than that of MSSA
(P < 0.001).  However, there were no signifi-
cant differences in the isolation rates of MRSA
among the groups with background diseases,
local injuries and senescence and/or bedridden
persons.
Patients with background diseases and se-
nescent or bedridden persons were not always
predisposed to MRSA.  Although only a few
specimens were analyzed, it appears that only
the immunosuppressive treatments might pre-
dispose patients to MRSA, and other factors
might include longer terms of treatment or hos-
pitalization.
Antibiotic resistance
The isolation rates of antibiotic-resistant strains
of staphylococci were investigated (Table 1).
Most (over 95%) MRSA were resistant to
ampicillin (ABPC), amoxicillin (AMPC) and
piperacillin (PIPC), and the isolation rates of
strains resistant to these PCs increased between
1993 and 1997 among total strains of staphylo-
cocci.  The isolation rates of resistant strains of
MSSA varied from 25% (PIPC and SBTPC) to
60% (AMPC).
Cephalosporin antibiotics, such as cefaclor
(CCL), cefazolin (CEZ), cefatrizine (CFT), cef-
metazole (CMZ), cefotiam (CTM) and cefta-
zidime (CAZ), were effective against MSSA,
but more than 90% of MRSA strains were resis-
tant to these cephalosporins, except for CMZ.
Strains resistant to various cephalosporins in-
creased gradually among all staphylococci
(data not shown).
MSSA was susceptible to flomoxef (FMOX),
imipenem/cilastatin (IPM/CS), latamoxef
(LMOX), but MRSA was less susceptible to
these antibiotics.
Arbekacin (ABK), minocycline (MINO) and
doxycycline (DOXY) were effective against
MRSA.  However, macrolides were not effective
Table 1.  Isolation rate of antibiotic-resistant
strains of MSSA, MRSA and total strains of
Staphylococcus spp.
Antibiotic      Number     Rate of resistant strains of:
   name of MSSA MRSA Total
strains tested (%) (%) (%)
 ABPC 903 57.3 94.0 72.2
 AMPC 348 67.4 96.7 74.7
 PIPC 1,062 24.6 96.8 79.6
 SBTPC 408 24.5 64.2 43.8
 CCL 804 16.2 96.3 52.1
 CEZ 1,136 4.9 96.0 51.4
 CMZ 1,195 3.0 71.4 39.8
 CTM 1,194 3.2 93.9 54.6
 CAZ 694 12.3 94.9 62.2
 SBT/CPZ 515 18.0 90.7 53.8
 FMOX 1,195 5.8 64.8 30.5
 IPM/CS 1,340 9.2 77.7 47.5
 LMOX 344 5.4 94.8 82.6
 ABK 381 2.3 3.0 2.7
 AMK 1,063 10.5 38.7 26.2
 DKB 381 36.1 36.9 34.9
 EM 75 36.3 92.2 60.9
 CLDM 428 30.5 86.2 55.4
 MINO 2,022 3.2 21.1 11.6
 DOXY 386 0.9 24.2 15.3
 NFLX 593 26.2 80.6 55.6
 OFLX 591 19.3 56.5 33.0
 LVFX 805 9.3 41.4 27.2
 FOM 1,054 12.3 72.1 45.3
 VCM 841 1.2 3.0 2.3
MRSA, methicillin-resistant Staphylococcus
aureus; MSSA, methicillin-sensitive Staphylococcus
aureus.
ABPC, ampicillin; AMPC, amoxicillin; PIPC,
piperacillin; SBTPC, sultamicillin; CCL, cefaclor;
CEZ, cefazolin; CMZ, cefmetazole; CTM, cefotiam;
CAZ, ceftazidime; SBT/CPZ, sulbactam/cefopera-
zone; FMOX, flomoxef; IPM/CS, imipenem/cila-
statin; LMOX, latamoxef; ABK, arbekacin; AMK,
amikacin; DKB, dibekacin; EM,  erythromycin;
MINO, minocycline; DOXY, doxycycline; CLDM,
clindamycin; NFLX, norfloxacin; OFLX, ofloxacin;
LVFX, levofloxacin; FOM, fosfomycin; VCM,
vancomycin.
against MRSA, and, for example the isolation
rate of MRSA resistant to erythromycin (EM) is
shown in Table 1.  New quinolone antibiotics had
various effects on MRSA, and the average rates of
antibiotic resistance to these agents were 40 to
80% throughout this 5 year period.
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Although MRSA was resistant to fosfo-
mycin (FOM) at a rate of 60% during this 5-year
period, very few strains of vancomycin (VCM)-
resistant MRSA were observed.
Discussion
Tottori Prefecture is located on Japan’s western
coast along the Sea of Japan, 200 km northwest
of Osaka.  It is one of the smallest prefectures in
Japan, having a population of about 630,000 in
an area of about 3,500 km2.  The chief indus-
tries are farming and fishery.  Tottori Prefecture
is thus a relatively isolated and rural district of
Japan.  However, this area is widely contaminat-
ed with MRSA, or multiply antibiotic-resistant
S. aureus.
Nosocomial infections with MRSA have
been observed in all parts of the world, especi-
ally in the advanced countries.  Careful surveil-
lance of MRSA has been performed in large
cities and districts (Aparicio, 1992; Marples and
Reith, 1992; Mylotte et al., 1992; Heffernan et al.,
1993; Ida et al., 1994; Voss et al., 1994; Zaman
and Dibb, 1994; Riley and Rouse, 1995; Maguire
et al., 1996; Johnson et al., 1997; Schmitz et al.,
1997).  Schmitz et al. (1997) observed the inci-
dence of MRSA isolates over a period of 3 years
and reported that from a total of 7,814 S. aureus
isolates, 6.3% were methicillin resistant.  Fur-
thermore, the highest incidence, 7.8%, was
found in a 1,500-bed hospital, and the lowest
incidence, 0.5%, was in a smaller 200-bed
hospital.  In a general hospital in Jaddah in
Saudi Arabia, the isolation frequency of MRSA
was 7.5% (Zaman and Dibb, 1994).  In US hos-
pitals, 66,132 S. aureus isolates were tested and
it was found that the percentage of MRSA rose
from 2.4% in 1975 to 29% in 1991, and that
hospitals with many beds (500 or more beds)
were higher in percent MRSA than hospitals
with few beds (< 200 beds) (Panlilio et al.,
1992)
.
The isolation frequency of MRSA in Japan
increased up to 60% by 1993 (Hashimoto, 1993),
which is a much higher incidence of MRSA
than those in the above-mentioned reports.  In
our surveys in Tottori Prefecture, the total isola-
tion rate of MRSA increased from 47% in 1993
to 63% in 1997, and was higher in general hos-
pitals than in clinics (Fig. 2).  The reasons why
the isolation rates of MRSA in hospitals were
higher than those in clinics were not clear.  Gen-
erally speaking, when a high dose of antibiotics
was used in hospitals, antibiotic-resistant
strains of microorganisms easily appeared in
the same circumstances.  The doctors in many
clinics used the antibiotics for several days only
on the patients, who were suspected of infection
before  isolation of microorganisms.  The pa-
tients attending the clinics may only come in
contact with antibiotics for relatively short
time.
The ratios of MRSA to MSSA in the age
group under 16 years of age and in the group over
65 years of age were significantly different from
those in the other age groups (both: P < 0.01).
The isolation frequency of MRSA in the group
under 16 years of age was lower and that in the
group over 65 years of age was higher than
those in the other groups (Fig. 3A).  These dif-
ferences are due to the fact that most of the pa-
tients over 65 years of age were bedridden pa-
tients with compromised conditions who were
hospitalized due to some diseases, whereas many
of the children under 16 years of age were out-
patients who visited clinics, and only a few
were admitted to the hospital.
Investigating the clinical specimens for iso-
lation of MRSA, 46% out of 1,449 MRSA strains
were isolated from sputum, and 19% were from
pus, although S. aureus strains were observed at
the rate of 34% in sputum and at the rate of 25%
in pus.  Ida et al. (1994) also reported that the
isolation frequency of MRSA was high in spu-
tum (42.9%) and pus (33.1%).  As shown in Fig.
3B, the isolation frequency of MRSA strains
from sputum was significantly higher, and that
from pus was lower, than that of total S. aureus
strains.  Sputum is collected for isolation of
bacterium from aged persons who are often in-
fected by opportunistic pathogens, and suffer
from chronic pulmonary diseases or general dis-
eases.  Pus was examined not only from decubi-
tus, but also from various lesions such as wound
infections, catheter insertions, post-operation
and local infections, and MRSA was often iso-
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lated from the decubitus that occurred in the
aged and bedridden persons.  However, wounds
were observed in persons of various ages (data
not shown), and this might be one reason why
the isolation rate of MRSA from pus was not as
high as that from sputum.
S. aureus has been one of the most dangerous
organisms causing nosocomial infections during
past 20 years.  Many guidelines have been con-
sidered and adopted to protect against noso-
comial infections (Crowcroft et al., 1996; Wenzel
et al., 1998).  Strategies for the surveillance and
control of MRSA include quantitative anti-
biogram (Marple and Reith, 1992; Panlilio et
al., 1992; Voss et al., 1994; Blanc et al., 1995;
Schito et al., 1996), phage-typing and DNA-
restriction map by pulsed-field gel electro-
phoresis (Aparicio et al., 1992; Mlynarczyk et
al., 1996)
.
According to the study reported by Ida et al.
(1996), more than 80% of MRSA strains were
highly resistant to methicillin, and were also re-
sistant to macrolide antibiotics and tobura-
mycin.  MRSA was also resistant to gentamicin
(60%), minocycline (50%) and ofloxacin (70%).
Only a small percentage of strains were resis-
tant to arbekacin, and most of the MRSA tested
were susceptible to vancomycin.  Schito et al.
(1996) reported that doxycycline, chloram-
phenicol, co-trimoxazole, ofloxacin and cipro-
floxacin (ratios of resistant strains:  < 1%) were
effective against MRSA.  Other authors report-
ed that MRSA was susceptible to vancomycin,
amikacin, bacitracin, chloramphenicol, framy-
cetin, fusidic acid and novobiocin (Riley and
Rouse, 1995).  Our study showed that only
vancomycin and arbekacin were effective
against MRSA, and that minocycline and doxy-
cycline were partially effective against MRSA
(Table 1).
In the course of comparing these data with
other reports, especially with reports from for-
eign countries (Aparicio et al., 1992; Marples
and Reith, 1992; Mylotte et al., 1992; Heffernan
et al., 1993; Voss et al., 1994; Zaman and Dibb,
1994; Riley and Rouse, 1995; Maguire et al.,
1996; Johnson et al., 1997; Schmitz et al., 1997), it
became clear that the isolation rates of MRSA
from patients in hospitals are exceptionally
high.  Even in a relatively isolated area like
Tottori Prefecture, the increased incidence of
MRSA has occurred.  There will be increasing
numbers of victims of MRSA infection, if we
leave MRSA as it is.  We must grapple with this
difficult problem.
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